stockportfolio.pro
Stocks / STOK vs UFPT
STOK vs UFPT
Stoke Therapeutics, Inc. and UFP Technologies, Inc. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
| Stoke Therapeutics, Inc. (STOK) | UFP Technologies, Inc. (UFPT) | |
|---|---|---|
| Market cap | $1.8B | $1.8B |
| Revenue (latest FY) | $184.42M | $602.80M |
| Net income (latest FY) | $-6.88M | $68.31M |
| Revenue growth (5y CAGR) | — | 27.4% |
| Net margin | -3.7% | 11.3% |
| Return on equity | -2.0% | 16.1% |
| P/E ratio | — | 26.5 |
| Dividend yield | — | — |
| Profitable years (of last 10) | 0 | 10 |
| Positive free cash flow | Yes | — |
Compare them properly — statement by statement
Open either company interactively: 19 years of income statement, balance sheet and cash flow, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open STOK — free Open UFPT — freeFrequently asked questions
Which is bigger, STOK or UFPT?
Stoke Therapeutics, Inc. is larger by market capitalization — $1.8B versus $1.8B.
Which grows faster, STOK or UFPT?
Five-year growth data is not available for both companies.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.